Review Article

Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives

Table 5

Pharmacokinetic parameters of DaunoXome compared to free daunorubicin.

ā€ƒHalf-life time (h)Plasma Clereance (mL/min)

Conventional daunorubicin
DaunoXome